The management of preterm labor

Obstetrics and Gynecology

Volumn 100, Issue 5, 2002, Pages 1020-1037

  Goldenberg, Robert L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; CALCIUM CHANNEL BLOCKING AGENT; CEFTIZOXIME; CLAVULANIC ACID; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; GLYCERYL TRINITRATE; INDOMETACIN; MAGNESIUM SULFATE; METRONIDAZOLE; MEZLOCILLIN; NIFEDIPINE; NITRIC OXIDE DONOR; OXYTOCIN ANTAGONIST; PENICILLIN DERIVATIVE; PROGESTERONE; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SULBACTAM; TERBUTALINE; TETRACYCLINE; UNINDEXED DRUG; UTERUS SPASMOLYTIC AGENT;

ANTIBIOTIC THERAPY; BED REST; CLINICAL PRACTICE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DELIVERY; ECHOGRAPHY; GASTROINTESTINAL DISEASE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HOME MONITORING; HOSPITAL; HUMAN; HYDRATION; HYPOTENSION; INTRAUTERINE INFECTION; LUNG EDEMA; MATERNAL DISEASE; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; OLIGOHYDRAMNIOS; PATIENT MONITORING; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY ARREST; RESUSCITATION; REVIEW; RISK FACTOR; SEDATION; STREPTOCOCCUS AGALACTIAE; TOCOLYSIS;

FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY;

EID: 0036855067     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1016/s0029-7844(02)02212-3     Document Type: Editorial

References (97)

1. Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Early Hum Dev 1999;53:193-218.
2. Hack M, Taylor HG, Klein N, Eiben R, Schatschneider C, Mercuri-Minich N. School-age outcomes in children with birth weights under 750 g. N Engl J Med 1994;331:753-9.
3. Tucker JM, Goldenberg RL, Davis RO, Copper RL, Winkler CL, Hauth JC. Etiologies of preterm birth in an indigent population: Is prevention a logical expectation? Obstet Gynecol 1991;77:343-7.
4. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm birth. N Engl J Med 2000;342:1500-7.
5. Guzick DS, Winn K. The association of chorioamnionitis with preterm delivery. Obstet Gynecol 1985;65:11-6.
6. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992;79:351-7.
7. Meis PJ, Ernest JM, Moore ML. Causes of low birthweight births in public and private patients. Am J Obstet Gynecol 1987;156:1165-8.
8. Wen SW, Goldenberg RL, Cutter G, Hoffman HJ, Cliver SP. Intrauterine growth retardation and preterm delivery: Prenatal risk factors in an indigent population. Am J Obstet Gynecol 1990;162:213-8.
9. Shiono PH, Klebanoff MA, Rhoads GG. Smoking and drinking during pregnancy. JAMA 1986;255:82-4.
10. Mercer BM, Goldenberg RL, Moawad AH, Meis PJ, Iams JD, Das AF, et al. The preterm prediction study: Effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1999;181:1216-21.
11. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstrom KD, eds. Williams obstetrics. 21st ed. New York: McGraw Hill, 2001:780.
12. Romero R, Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteruria and preterm delivery/birth weight. Obstet Gynecol 1989;73:576-82.
13. Nageotte MP, Dorchester W, Porto M, Keegan KA Jr, Freeman RK. Quantitation of uterine activity preceding preterm, term, and postterm labor. Am J Obstet Gynecol 1988;158:1254-9.
14. Copper RL, Goldenberg RL, Dubard MB, Hauth JC, Cutter GR. Cervical examination and tocodynamometry at 28 weeks’ gestation: Prediction of spontaneous preterm birth. Am J Obstet Gynecol 1995;172:666-71.
15. Iams JD, Newman RB, Thom EA, Goldenberg RL, Mueller-Heubach E, Moawad A, et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med 2002;346:250-5.
16. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 1997;177:13-8.
17. Goldenberg RL, Iams JD, Das A, Mercer BM, Meis PJ, Moawad AH, et al. The preterm prediction study: Fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996;87:636-43.
18. Okitsu O, Mimura T, Nakayama T, Aono T. Early prediction of preterm delivery by transvaginal ultrasonography. Ultrasound Obstet Gynecol 1992;2:402.
19. Newman RB, Gill PJ, Wittreich P, Katz M. Maternal perception of prelabor uterine activity. Obstet Gynecol 1986;68:765-9.
20. Dyson DC, Danbe KH, Bamber JA, Crites YM, Field DR, Maier JA, et al. Monitoring women at risk for preterm labor. N Engl J Med 1998;338:15.
21. Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW, Mennemeyer ST. Bed rest in pregnancy. Obstet Gynecol 1994;84:131-6.
22. Pircon RA, Strassner HT, Kirz DS, Towers CV. Controlled trial of hydration and bed rest versus bed rest alone in the evaluation of preterm uterine contractions. Am J Obstet Gynecol 1989;161:775-9.
23. Guinn DA, Goepfert AR, Owen J, Brumfield C, Hauth JC. Management options in women with preterm uterine contractions: A randomized clinical trial. Am J Obstet Gynecol 1997;177:814-8.
24. Helfgott AW, Willis D, Blanco J. Is sedation beneficial in the treatment of threatened preterm labor? A preliminary report. J Matern Fetal Med 1994;3:37-42.
25. Keirse MJ. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990;97:149-54.
26. Fuchs AR, Stakemann G. Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 1960;79:172-6.
27. Ovlisen B, Iversen J. Treatment of threatened premature labor with 6α-methyl-17α-acetoxyprogesterone. Am J Obstet Gynecol 1963;86:291-5.
28. Barden TP, Peter JB, Merkatz IR. Ritodrine hydrochloride: A beta-mimetic agent for use in preterm labor. I. Pharmacology, clinical history, administration, side effects, and safety. Obstet Gynecol 1980;56:1-6.
29. Merkatz JR, Peter JB, Barden TP. Ritodrine hydrochloride: A beta-mimetic agent for use in preterm labor. II. Evidence of efficacy. Obstet Gynecol 1980;56:7-12.
30. Canadian Preterm Labor Investigators Group. The treatment of preterm labor with beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-12.
31. King JF, Grant A, Keirse MJ, Chalmers I. Beta-mimetics in preterm labour: An overview of randomized, controlled trials. Br J Obstet Gynaecol 1998;95:211-22.
32. Caritis SN, Venkataramanan R, Darby MJ, Chiao JP, Krew M. Pharmacokinetics of ritodrine administered intravenously: Recommendations for changes in the current regimen. Am J Obstet Gynecol 1990;162:429-37.
33. Groome LJ, Goldenberg RL, Cliver SP, Davis RO, Copper RL. Neonatal periventricular-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis. Am J Obstet Gynecol 1992;167:873-9.
34. Ingemarsson I. Effect of terbutaline on premature labor. Am J Obstet Gynecol 1976;125:520-4.
35. Lam F, Gill P, Smith M, Kitzmiller JL, Katz M. Use of the subcutaneous terbutaline pump for long-term tocolysis. Obstet Gynecol 1988;72:810-3.
36. Guinn DA, Goepfert AR, Owen J, Wenstrom KD, Hauth JC. Terbutaline pump maintenance therapy for prevention of preterm delivery: A double-blind trial. Am J Obstet Gynecol 1998;179:874-8.
37. Steer CM, Petrie RH. A comparison of magnesium sulfate and alcohol for the prevention of premature labor. Am J Obstet Gynecol 1977;129:1-4.
38. Miller JM, Keane MW, Horger EO 3rd. A comparison of magnesium sulfate and terbutaline for the arrest of premature labor. J Reprod Med 1982;27:348-51.
39. Martin RW, Perry KG Jr, Hess LW, Martin JN Jr, Morrison JC. Oral magnesium and the prevention of preterm labor in a high-risk group of patients. Am J Obstet Gynecol 1992;166:144-7.
40. Ricci JM, Hariharan S, Helfgott A, Reed K, O’Sullivan MJ. Oral tocolysis with magnesium chloride: A randomized controlled prospective clinical trial. Am J Obstet Gynecol 1991;165:603-10.
41. Ridgeway LE 3rd, Muise K, Wright JW, Patterson RM, Newton ER. A prospective randomized comparison of oral terbutaline and magnesium oxide for the maintenance of tocolysis. Am J Obstet Gynecol 1990;163:879-82.
42. Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulfate and nifedipine: A cause of neuromuscular blockade. Br J Obstet Gynaecol 1994;101:262-3.
43. Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol 2000;183:717-25.
44. Zuckerman H, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974; 44:787-92.
45. Niebyl JR, Blake DA, White RD, Kumor KM, Dubin NH, Robinson JC, et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol 1980;136:1014-9.
46. Morales WJ, Smith SG, Angel JL, O’Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: A randomized study. Obstet Gynecol 1989;74:567-72.
47. Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: A randomized study. Am J Obstet Gynecol 1993;169:97-102.
48. Norton ME, Merrill J, Cooper BA, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med 1993;329:1602-7.
49. Ulmsten U, Andersson KE, Wingerup L. Treatment of premature labor with the calcium antagonist nifedipine. Arch Gynecol 1980;229:1-5.
50. Read MD, Wellby DE. The use of a calcium antagonist (nifedipine) to suppress preterm labour. Br J Obstet Gynaecol 1986;93:933-7.
51. Ferguson JE II, Dyson DC, Schutz T, Stevenson DK. A comparison of tocolysis with nifedipine or ritodrine: Analysis of efficacy and maternal, fetal, and neonatal outcome. Am J Obstet Gynecol 1990;163:105-11.
52. Koks CA, Brolmann HA, de Kleine MJ, Manger PA. A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. Eur J Obstet Gynecol Reprod Biol 1998;77:171-6.
53. Papatsonis DN, Kok JH, van Geijn HP, Bleker OP, Ader HJ, Dekker GA. Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet Gynecol 200;95:477-81.
54. Tsatsaris V, Papatsonis D, Goffinet F, Dekker G, Carbonne B. Tocolysis with nifedipine or beta-adrenergic agonists: A meta-analysis. Obstet Gynecol 2001;97:840-7.
55. Haghighi L. Prevention of preterm delivery: Nifedipine or magnesium sulfate. Int J Gynaecol Obstet 1999;66:297-8.
56. Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: A randomized study. Am J Obstet Gynecol 1993; 169:960-4.
57. Carr DB, Clark AL, Kernek K, Spinnato JA. Maintenance oral nifedipine for preterm labor: A randomized clinical trial. Am J Obstet Gynecol 1999;181:822-7.
58. Mari G, Kirshon B, Moise KJ Jr, Lee W, Cotton DB. Doppler assessment of the fetal and uteroplacental circulation during nifedipine therapy for preterm labor. Am J Obstet Gynecol 1989;161:1514.
59. Akerlund M, Stromberg P, Hauksson A, Andersen LF, Lyndrup J, Trojnar J, et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 1987;94:1040-4.
60. Andersen LF, Lyndrup J, Akerlund M, Melin P. Oxytocin receptor blockade: A new principle in the treatment of preterm labor? Am J Perinatol 1989;6:196-9.
61. Goodwin TM, Paul R, Silver H, Spellacy W, Parsons M, Chez R, et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994;170:474.
62. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, et al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol 2000;182:1173-83.
63. Moutquin JM, Sherman D, Cohen H, Mohide PT, Hochner-Celnikier D, Fejgin M, et al. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191-9.
64. The Worldwide Atosiban Versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Br J Obstet Gynaecol 2001;108:133-42.
65. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koltun WD, Millar L, et al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. The Atosiban PTL-098 Study Group. Am J Obstet Gynecol 2000;182:1184-90.
66. Lees CC, Lojacono A, Thompson C, Danti L, Black RS, Tanzi P, et al. Glyceryl trinitrate and ritodrine in tocolysis: An international multicenter randomized study. GTN Preterm Labour Investigation Group. Obstet Gynecol 1999; 94:403-8.
67. El-Sayed YY, Riley ET, Holbrook RH Jr, Cohen SE, Chitkara U, Druzin ML. Randomized comparison of intravenous nitroglycerin and magnesium sulfate for treatment of preterm labor. Obstet Gynecol 1999;93:79-83.
68. Drugs in threatened preterm labour [editorial]. Br Med J 1979;I:71.
69. Gyetvai K, Hannah ME, Hodnett ED, Ohlsson A. Tocolytics for preterm labor: A systematic review. Obstet Gynecol 1999;94:869-77.
70. Elder HA, Santamarina BA, Smith S, Kass EH. The natural history of asymptomatic bacteriuria during pregnancy: The effect of tetracycline on the clinical course and outcome of pregnancy. Am J Obstet Gynecol 1971;111:441-62.
71. King J, Flenady V. Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev 2000;2:CD000246.
72. Mazor M, Chaim W, Maymon E, Hershkowitz R, Romero R. The role of antibiotic therapy in the prevention of prematurity. Clin Perinatol 1998;25:659-85.
73. Thorp JM, Hartmann KE, Berkman ND, Carey TS, Lohr KN, Gavin NI, et al. Antibiotic therapy for the treatment of preterm labor: A review of the evidence. Am J Obstet Gynecol 2002;186:587-92.
74. McGregor JA, French JI, Reller LB, Todd JK, Makowski EL. Adjunctive erythromycin treatment for idiopathic preterm labor: Results of a randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1986;154:98-103.
75. Morales WJ, Angel JL, O’Brien WF, Knuppel RA, Finazzo M. A randomized study of antibiotic therapy in idiopathic preterm labor. Obstet Gynecol 1988;72:829-33.
76. Newton ER, Dinsmoor MJ, Gibbs RS. A randomized blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor. Obstet Gynecol 1989;74:562-6.
77. McGregor JA, French JI, Seo K. Adjunctive clindamycin therapy for preterm labor: Results of a double-blind, placebo-controlled trial. Am J Obstet Gynecol 1991;165:867-75.
78. Newton ER, Shields L, Ridgway LE 3rd, Berkus MD, Elliott BD. Combination antibiotics and indomethacin in idiopathic preterm labor: A randomized double-blind clinical trial. Am J Obstet Gynecol 1991;165:1753-9.
79. McCaul JF, Perry KG Jr, Moore JL Jr, Martin RW, Bucovaz ET, Morrison JC. Adjunctive antibiotic treatment of women with preterm rupture of membranes or preterm labor. Int J Gynaecol Obstet 1992;38:19-24.
80. Romero R, Sibai B, Caritis S, Paul R, Depp R, Rosen M, et al. Antibiotic treatment of preterm labor with intact membranes: A multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1993;169:764-74.
81. Norman K, Pattinson RC, de Souza J, de Jong P, Moller G, Kirsten G. Ampicillin and metronidazole treatment in preterm labour: A multicentre, ramdomised controlled trial. Br J Obstet Gynaecol 1994;101:404-8.
82. Watts DH, Krohn MA, Hillier SL, Eschenbach DA. Randomized trial of antibiotics in addition to tocolytic therapy to treat preterm labor. Infect Dis Obstet Gynecol 1994;1:220-7.
83. Gordon M, Samuels P, Shubert P, Johnson F, Gebauer C, Iams J. A randomized, prospective study of adjunctive ceftizoxime in preterm labor. Am J Obstet Gynecol 1995; 172:1546-52.
84. Cox SM, Bohman VR, Sherman L, Leveno KJ. Randomized investigation of antimicrobials for the prevention of preterm birth. Am J Obstet Gynecol 1996;174:206-10.
85. Svare J, Langhoff-Roos J, Anderson LF, Kryger-Baggesen N, Borch-Christensen H, Heisterberg L, et al. Ampicillin-metronidazole treatment in idiopathic preterm labour: A randomised controlled multicentre trial. Br J Obstet Gynaecol 1997;104:892-7.
86. Oyarzun E, Gomez R, Rioseco A, Gonazalez P, Gutierrez P, Donoso E, et al. Antibiotic treatment in preterm labor and intact membranes: A randomized, double-blinded, placebo-controlled trial. J Matern Fetal Med 1998;7:105-10.
87. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for spontaneous preterm labour: The ORACLE II randomised trial. Lancet 2001;357:989-94.
88. Thomsen AC, Morup L, Hansen KB. Antibiotic elimination of group B streptococci in urine in prevention of preterm labour. Lancet 1987;1:591-3.
89. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep 1996; 45(RR-7):1.
90. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50:515-25.
91. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000;2:CD000065.
92. National Institutes of Health (NIH) Consensus Development Conference. Effect of corticosteroids for fetal maturation on perinatal outcomes. Am J Obstet Gynecol 1995; 173:246.
93. Baud O, Foix-L’Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6.
94. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 265. Mode of term single breech delivery. Obstet Gynecol 2001;98:1189-90.
95. Goldenberg RL, Davis RO. in caul delivery of the very premature infant. Am J Obstet Gynecol 1983;145:645-6.
96. Goldenberg RL, Rouse DJ. The prevention of premature birth. N Engl J Med 1998;339:313-20.
97. Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM. Births: Final data for 2000. Natl Vital Stat Rep 2002;50(5):1-101.